arrow
G

Gonzalo Luis Alonso Salinas

Institute for Health Research of Navarra
H指数:17
被引数:1,012

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Associations of Mediterranean Diet Adherence with Cardiometabolic Outcomes, Psychological Symptoms, and Health-Related Quality of Life Among Adults Attending Primary Care Centres in Navarra, Spain: A Cross-Sectional Study

地中海饮食依从性与纳瓦拉地区成人心血管代谢结局、心理症状及健康相关生活质量的关系:一项横断面研究

2026-09-270
OA
Macroalbuminuria as a marker of cardiac damage in patients with type 2 diabetes: insights from multimodality cardiac imaging and biomarkers

2型糖尿病患者中,大量白蛋白尿作为心脏损伤的标志物:多模态心脏成像和生物标志物的启示

2026-09-210
OAAI
Machine learning models based on routinely collected primary care data for documented diabetic retinopathy and nephropathy: development and internal validation

基于常规收集的初级保健数据的机器学习模型用于记录糖尿病视网膜病变和肾病:开发和内部验证

2026-09-100
OA
Respiratory Syncytial Virus Vaccination as Cardiopulmonary and Cardiovascular Risk Mitigation in Adults with Heart Disease

呼吸道合胞病毒疫苗接种作为心脏病患者的心肺和心血管风险缓解措施

2026-09-010
OA
Clinical phenotypes of type 2 diabetes and their association with microvascular complications in primary care: a cluster analysis

2型糖尿病的临床表型及其与微血管并发症在初级保健中的关联:一项聚类分析

2026-07-060
OAAI
Clinical Trials in Older Adults with Cardiovascular Multimorbidity: A Perspective on Pragmatic Trial Design

心血管多病共存老年患者的临床试验:实用试验设计的视角

2026-06-100
OAAI
Validation of Electrocardiographic Recording in Smartwatches for the Diagnosis of Non-ST-Segment Elevation Acute Coronary Syndrome. Preliminary Analysis of the ACS WATCH II

智能手表心电图记录在非ST段抬高急性冠状动脉综合征诊断中的验证。ACS WATCH II的初步分析

2025-07-010
OA
Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry

finerenone在心力衰竭患者中的临床实用性和安全性: 精细注册的原理和设计

2025-02-010
OAAI
Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN study

早期乳腺癌携带胚系BRCA1/2突变患者中蒽环类药物诱导的心脏毒性:BRCAN研究

2024-11-190
OA
Vaccine-carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination
2023-06-274
PRE